PADIGLIONI, SONIA
 Distribuzione geografica
Continente #
NA - Nord America 1.166
EU - Europa 958
AS - Asia 265
AF - Africa 2
SA - Sud America 1
Totale 2.392
Nazione #
US - Stati Uniti d'America 1.160
RU - Federazione Russa 575
IT - Italia 123
IE - Irlanda 98
SE - Svezia 92
SG - Singapore 83
CN - Cina 62
HK - Hong Kong 58
DE - Germania 27
IN - India 26
JO - Giordania 26
GB - Regno Unito 11
FI - Finlandia 7
KR - Corea 7
CH - Svizzera 6
CA - Canada 5
ES - Italia 4
AT - Austria 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
FR - Francia 2
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 2.392
Città #
Santa Clara 319
Chandler 126
Fairfield 105
Dublin 98
Ashburn 69
Singapore 62
Seattle 55
Woodbridge 42
Houston 41
Moscow 39
Hong Kong 38
Cambridge 31
Altamura 29
Lawrence 28
Wilmington 28
Bremen 23
Mumbai 21
Florence 20
Shanghai 17
Princeton 15
Buffalo 14
New York 12
Beijing 11
Ann Arbor 10
Kent 9
Medford 9
West Jordan 8
Boston 7
Bern 6
Helsinki 6
Yubileyny 6
Dearborn 5
Los Angeles 5
Seoul 5
Arezzo 4
Boardman 4
Pune 4
Toronto 4
Como 3
Duncan 3
Falls Church 3
Kunming 3
London 3
Milan 3
Norwalk 3
Palermo 3
San Diego 3
Abidjan 2
Casamarciano 2
Colle di Val d'Elsa 2
Dallas 2
Guangzhou 2
Manchester 2
Monza 2
Naples 2
Pisa 2
Poggibonsi 2
Prescot 2
Suwon 2
Turin 2
Vienna 2
Andover 1
Athens 1
Bagno A Ripoli 1
Baku 1
Barcelona 1
Bitola 1
Bologna 1
Brentford 1
Brussels 1
Böblingen 1
Campi Bisenzio 1
Chennai 1
Copenhagen 1
Fiesole 1
Fuzhou 1
Harbin 1
Hebei 1
Hillsboro 1
Hounslow 1
Kilburn 1
Kumamoto 1
Lappeenranta 1
Laurel 1
Lisbon 1
Lucca 1
Madrid 1
Nanchang 1
Nantong 1
Napoli 1
Osimo 1
Panama City 1
Pinerolo 1
Prague 1
Redwood City 1
Rio de Janeiro 1
Rome 1
Romola 1
Serra 1
Shenyang 1
Totale 1.429
Nome #
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 133
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 127
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 118
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 111
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 110
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 109
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 103
Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation 93
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 92
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 88
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 88
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 82
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 81
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 78
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 69
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 66
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 66
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 64
null 63
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 62
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 61
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 60
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 57
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 53
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 52
Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment 44
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 43
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 38
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 38
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 36
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 36
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 33
Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD 30
Do Cholinesterase Inhibitors Act Primarily on Attention Deficit? A Naturalistic Study in Alzheimer's Disease Patients 25
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 16
Totale 2.425
Categoria #
all - tutte 10.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 0 0 0 0 34 28 30 25 24 19 18 8
2020/2021129 13 9 2 22 8 6 4 11 23 8 13 10
2021/202299 5 1 7 4 2 7 0 13 4 5 18 33
2022/2023548 58 113 37 41 35 88 61 27 68 1 11 8
2023/2024299 5 23 25 11 18 38 21 68 7 44 22 17
2024/20251.113 69 202 120 329 393 0 0 0 0 0 0 0
Totale 2.425